Dong Joon Kim

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Venues

Phytotherapy research : PTR

International journal of molecular sciences

Molecular carcinogenesis

Oncogene

China-US (Henan) Hormel Cancer Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

China-US (Henan) Hormel Cancer Institute Jan 30 2016

China

PHD :: Molecular and Cellular Biology

Publications

So Jeong Paik, Dong Joon Kim, Sung Keun Jung
Preventive Effect of Pharmaceutical Phytochemicals Targeting the Src Family of Protein Tyrosine Kinases and Aryl Hydrocarbon Receptor on Environmental Stress-Induced Skin Disease. International journal of molecular sciences 24 (6) (2023)
So Jeong Paik, Dong Joon Kim, Sung Keun Jung
Preventive Effect of Pharmaceutical Phytochemicals Targeting the Src Family of Protein Tyrosine Kinases and Aryl Hydrocarbon Receptor on Environmental Stress-Induced Skin Disease. International journal of molecular sciences 24 (6) (2023)
Dong Joon Kim, Yong Weon Yi, Yeon Sun Seong
Beta-Transducin Repeats-Containing Proteins as an Anticancer Target. Cancers 15 (17) (2023)
So Jeong Paik, Dong Joon Kim, Sung Keun Jung
Preventive Effect of Pharmaceutical Phytochemicals Targeting the Src Family of Protein Tyrosine Kinases and Aryl Hydrocarbon Receptor on Environmental Stress-Induced Skin Disease. International journal of molecular sciences 24 (6) (2023)
Xiaomeng Xie, Kyle Vaughn Laster, Jian Li, Wenna Nie, Yong Weon Yi, Kangdong Liu, Yeon-Sun Seong, Zigang Dong, Dong Joon Kim
OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer. Cellular and molecular life sciences : CMLS 80 (9) (2023)
Xiangyu Wang, Xiaomeng Xie, Yuanyuan Zhang, Fayang Ma, Mengjun Pang, Kyle Vaughn Laster, Xiang Li, Kangdong Liu, Zigang Dong, Dong Joon Kim
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma. Cellular oncology (Dordrecht) 45 (1) (2022)
Yuanyuan Zhang, Xiaodan Shi, Xiaomeng Xie, Kyle Vaughn Laster, Mengjun Pang, Kangdong Liu, Joonsung Hwang, Dong Joon Kim
Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR. Phytotherapy research : PTR 35 (11) (2021)
Qiong Wu, Fangfang Liu, Mengmeng Ge, Kyle Vaughn Laster, Lixiao Wei, Ruijuan Du, Ming Jiang, Jing Zhang, Yafei Zhi, Guoguo Jin, Simin Zhao, Dong Joon Kim, Zigang Dong, Kangdong Liu
BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression. Oncogene (2021)
Xiaomeng Xie, Xiangyu Wang, Xiaodan Shi, Yuanyuan Zhang, Kyle Vaughn Laster, Kangdong Liu, Zigang Dong, Dong Joon Kim
Anwulignan is a novel JAK1 inhibitor that suppresses non-small cell lung cancer growth. Journal of cellular and molecular medicine 25 (5) (2021)
Xueyin Zu, Xiaomeng Xie, Yuanyuan Zhang, Kangdong Liu, Ann M Bode, Zigang Dong, Dong Joon Kim
Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells. Phytotherapy research : PTR 33 (9) (2019)
Xiaomeng Xie, Xueyin Zu, Feifei Liu, Ting Wang, Xiangyu Wang, Hanyong Chen, Kangdong Liu, Penglei Wang, Fangfang Liu, Yan Zheng, Ann M Bode, Zigang Dong, Dong Joon Kim
Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo. Molecular carcinogenesis 58 (7) (2019)
Li Wang, Xiangyu Wang, Hanyong Chen, Xueyin Zu, Fayang Ma, Kangdong Liu, Ann M Bode, Zigang Dong, Dong Joon Kim
Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2. Phytotherapy research : PTR 33 (3) (2018)
Feifei Liu, Xueyin Zu, Xiaomeng Xie, Kangdong Liu, Hanyong Chen, Ting Wang, Fangfang Liu, Ann M Bode, Yan Zheng, Zigang Dong, Dong Joon Kim
Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient-derived esophageal tumor growth. Molecular carcinogenesis 58 (4) (2018)

Dong Joon Kim.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dong Joon Kim